Home > Boards > Canadian > Medical - Drugs > Syndax Pharmaceuticals Inc (SNDX)

SNDX ENCORE-601 update…

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 752
Posts 116,068
Boards Moderated 12
Alias Born 09/05/02
160x600 placeholder
Buy These 2 Stocks Before They Jump Over 60%, Says Analyst TipRanks - 6/7/2021 8:38:51 PM
Syndax Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference PR Newswire (US) - 6/3/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:46:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2021 4:03:25 PM
Syndax Announces Participation in Cowen 2nd Annual Virtual Oncology Innovation Summit PR Newswire (US) - 5/13/2021 7:00:00 AM
Syndax Pharma announces new data for SNDX-5613 in trial for acute leukemias Seeking Alpha - 5/11/2021 4:32:34 PM
Syndax Pharmaceuticals EPS beats by $0.13, beats on revenue Seeking Alpha - 5/11/2021 4:14:56 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/11/2021 4:13:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2021 4:12:48 PM
Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical and Business Update PR Newswire (US) - 5/11/2021 4:01:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/10/2021 4:05:43 PM
Syndax to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11, 2021 PR Newswire (US) - 5/4/2021 7:00:00 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/3/2021 3:15:57 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2021 4:04:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/28/2021 4:16:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2021 5:07:36 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 4/20/2021 4:35:53 PM
Syndax's SNDX-5613 shows robust clinical activity in patients with acute leukemias Seeking Alpha - 4/20/2021 8:32:54 AM
Syndax Announces Positive Interim Data Demonstrating Robust Clinical Activity in Phase 1 Portion of the AUGMENT-101 Trial of ... PR Newswire (US) - 4/20/2021 7:00:00 AM
Syndax Pharmaceuticals to Host Conference Call and Webcast to Provide Updated Data from Phase 1 Portion of AUGMENT-101 Trial ... PR Newswire (US) - 4/15/2021 7:00:00 AM
Syndax Pharma’s Axatilimab Receives Orphan Drug Designation For Treatment Of Chronic Lung Disease TipRanks - 4/9/2021 5:43:54 AM
Syndax wins FDA’s orphan drug designation for axatilimab in chronic lung disease Seeking Alpha - 4/8/2021 4:49:19 PM
Syndax Announces Orphan Drug Designation Granted to Axatilimab for Treatment of Idiopathic Pulmonary Fibrosis PR Newswire (US) - 4/8/2021 4:30:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/1/2021 5:19:51 PM
Syndax Announces Orphan Drug Designation Granted to Axatilimab for Treatment of Chronic Graft Versus Host Disease PR Newswire (US) - 3/31/2021 7:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences